GARVEY, David S.,LAROSA, Gregory J.,GREENWOOD, Jeremy R.,FRYE, Leah L.,QUACH, Tan,COTE, Jamie B.,BERMAN, Judd
申请号：
AU2016273882
公开号：
AU2016273882B2
申请日:
2016.12.14
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2016273882B220181108.pdf#####PEPTIDE ANALOGS FOR TREATING DISEASES AND DISORDERS ABSTRACT A peptide having a sequence selected from SEQ ID NO: 11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18. Said peptide used for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of appetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.
